Next Article in Journal
Effects of Moxifloxacin on Human Neutrophil and T-Lymphocyte Functions in Vitro
Next Article in Special Issue
Therapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees
Previous Article in Journal
Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2010, 3(12), 3543-3569; doi:10.3390/ph3123543

Anticoagulation in the Elderly

Division of Angiology and Hemostasis, Department of Internal Medicine, Geneva University Hospital and Faculty of Medicine, 4 rue Gabrielle Perret-Gentil CH-1211 Geneva 14, Switzerland
Author to whom correspondence should be addressed.
Received: 7 October 2010 / Revised: 7 December 2010 / Accepted: 9 December 2010 / Published: 10 December 2010
(This article belongs to the Special Issue Anticoagulants)
View Full-Text   |   Download PDF [240 KB, 13 December 2010; original version 10 December 2010]   |  


Management of anticoagulation in elderly patients represents a particularly challenging issue. Indeed, this patient population is at high thromboembolic risk, but also at high hemorrhagic risk. Assessment of the benefit-risk balance of anticoagulation is the key point when decisions are made about introducing and/or continuing such treatments in the individual elderly patient. In order to maximise the safety of anticoagulation in the elderly, some specific considerations need to be taken into account, including renal insufficiency, modified pharmacodynamics of anticoagulants, especially vitamin K antagonists, and the presence of multiple comorbidities and concomitant medications. New anticoagulants could greatly simplify and possibly increase the safety of anticoagulation in the elderly in the near future.
Keywords: anticoagulation; elderly patient; vitamin K antagonist; hemorrhagic risk; factor-Xa inhibitor; thrombin inhibitors anticoagulation; elderly patient; vitamin K antagonist; hemorrhagic risk; factor-Xa inhibitor; thrombin inhibitors
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Robert-Ebadi, H.; Righini, M. Anticoagulation in the Elderly. Pharmaceuticals 2010, 3, 3543-3569.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top